Portola Pharmaceuticals Inc: 25-NSE filed Jul 2, 2020

Form type
25-NSE
Filing date
Jul 2, 2020
Accession number
0001354457-20-000313
Filer
Portola Pharmaceuticals Inc (CIK 1269021)